IL108183A0 - Pharmaceutical compositions for transdermal hormone replacement therapy - Google Patents
Pharmaceutical compositions for transdermal hormone replacement therapyInfo
- Publication number
- IL108183A0 IL108183A0 IL10818393A IL10818393A IL108183A0 IL 108183 A0 IL108183 A0 IL 108183A0 IL 10818393 A IL10818393 A IL 10818393A IL 10818393 A IL10818393 A IL 10818393A IL 108183 A0 IL108183 A0 IL 108183A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- replacement therapy
- hormone replacement
- transdermal hormone
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99682092A | 1992-12-28 | 1992-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL108183A0 true IL108183A0 (en) | 1994-04-12 |
Family
ID=25543344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10818393A IL108183A0 (en) | 1992-12-28 | 1993-12-27 | Pharmaceutical compositions for transdermal hormone replacement therapy |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0675720A1 (en) |
| CN (1) | CN1097987A (en) |
| CA (1) | CA2152780A1 (en) |
| IL (1) | IL108183A0 (en) |
| MX (1) | MXPA94000108A (en) |
| SI (1) | SI9300687A (en) |
| WO (1) | WO1994014450A1 (en) |
| ZA (1) | ZA939686B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5855920A (en) * | 1996-12-13 | 1999-01-05 | Chein; Edmund Y. M. | Total hormone replacement therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| HU214598B (en) * | 1987-09-24 | 1998-04-28 | Jencap Research Ltd | Process for producing contraceptive compositions containing estragen and progestin and applicable for hormonal therapy |
-
1993
- 1993-12-24 WO PCT/CA1993/000564 patent/WO1994014450A1/en not_active Application Discontinuation
- 1993-12-24 CA CA002152780A patent/CA2152780A1/en not_active Abandoned
- 1993-12-24 EP EP94904111A patent/EP0675720A1/en not_active Withdrawn
- 1993-12-27 IL IL10818393A patent/IL108183A0/en unknown
- 1993-12-27 SI SI9300687A patent/SI9300687A/en unknown
- 1993-12-27 ZA ZA939686A patent/ZA939686B/en unknown
- 1993-12-28 CN CN93121739A patent/CN1097987A/en active Pending
-
1994
- 1994-01-03 MX MXPA94000108A patent/MXPA94000108A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0675720A1 (en) | 1995-10-11 |
| CN1097987A (en) | 1995-02-01 |
| ZA939686B (en) | 1994-08-29 |
| SI9300687A (en) | 1994-09-30 |
| WO1994014450A1 (en) | 1994-07-07 |
| MXPA94000108A (en) | 2004-08-20 |
| CA2152780A1 (en) | 1994-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117728A0 (en) | Pharmaceutical compositions for transdermal administration | |
| ZA899112B (en) | Compositions for transdermal delivery of estradiol | |
| GB2264235B (en) | Composition for nasal treatment | |
| GB9319500D0 (en) | Pharmaceutical composition | |
| GB9204354D0 (en) | Compounds for medicinal use | |
| AU2345695A (en) | Pharmaceutical composition for transdermal delivery | |
| GB2272375B (en) | Pharmaceutical composition | |
| EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
| IL104409A0 (en) | Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy | |
| IL108197A0 (en) | Pharmaceutical composition for preventing or treating arterioscleriosis | |
| ZA937592B (en) | Pharmaceutical composition | |
| IL108183A0 (en) | Pharmaceutical compositions for transdermal hormone replacement therapy | |
| ZA94155B (en) | Pharmaceutical composition | |
| ZA935078B (en) | Pharmaceutical composition | |
| ZA89552B (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
| IL93143A0 (en) | Transdermal drug delivery composition | |
| NZ268125A (en) | Growth hormone pharmaceutical composition | |
| ZA935931B (en) | Pharmaceutical composition | |
| ZA924061B (en) | Pharmaceutical composition | |
| ZA931984B (en) | Pharmaceutical composition | |
| IL95508A0 (en) | Pharmaceutical compositions for transdermal administration | |
| GB9206151D0 (en) | Nasal pharmaceutical composition | |
| GB9214591D0 (en) | Therapeutic composition | |
| IE871371L (en) | Compositions for transdermal therapeutic systems of¹diuretics | |
| EG20185A (en) | Drug material suitable for micronisation |